|[August 30, 2013]
The Shuman Law Firm Investigates NuVasive, Inc.
BOULDER, Colo. --(Business Wire)--
Shuman Law Firm announces that it is investigating potential claims
against certain officers and directors of NuVasive, Inc. ("NuVasive" or
the "Company") (NASDAQ: NUVA).
NuVasive is a California-based a medical device company that engages in
the design, development, and marketing of minimally disruptive surgical
products and procedurally integrated solutions for the spine.
The Firm's investigation concerns the Company's July 30, 2013,
disclosure that it had "received a subpoena from the Office of the
Inspector General of the U.S. Department of Health and Human Services in
connection with an investigation into possible false or otherwise
improper claims submitted to Medicare and Medicaid." The subpoena seeks
documents for the period January 2007 through April 2013. Since this
announcement, shares of NuVasive have fallen $3.28 per share or 13% to
close at $22.82 on July 31, 2013.
If you currently own NuVasive common stock and are interested in
discussing your rights as a shareholder, or have information relating to
this investigation, please contact Kip B. Shuman or Rusty E. Glenn toll
free at (866) 974-8626 or email Mr. Shuman at firstname.lastname@example.org
or email Mr. Glenn at email@example.com.
The Shuman Law Firm represents investors throughout the nation,
concentrating its practice in stockholder litigation.
[ Back To Technology News's Homepage ]